Drugs / Sofosbuvir / Velpatasvir
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04997564 | Aug 2021 → Dec 2023 | chronic hepatitis B virus infection, chronic hepatitis C virus infection | Peking University First Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sofosbuvir / Velpatasvir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04997564 ↗ |